Disease: Graft Versus Host Disease
- A More MAGICal Alogrithm in Acute GVHD
- A new vision of the efficacy of both CAR-NK and CAR-T cells in treating cancers and autoimmune diseases
- A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone
- A placebo-controlled, crossover trial to investigate the efficacy of tiotropium bromide or placebo added to usual care in stable symptomatic post-hematopoietic stem cell transplantation (HSCT) bronchiolitis obliterans syndrome (BOS)
- Acquired angioedema as a late-onset complication after cord blood transplantation: a subtype of chronic graft-versus-host disease
- Acute calcareous corneal degeneration in a patient with chronic graft-versus-host disease
- Acute Graft versus Host Disease in Beta Thalassemia Patients Following Allogeneic Haematopoietic Stem Cell Transplantation
- Acute onset of constrictive pericarditis due to acute myelomonocytic leukemia: A case and literature review
- Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients
- Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period
- Allogenic hematopoietic stem cell transplantation in an Iranian patient with osteopetrosis caused by carbonic anhydrase II deficiency: A case report
- Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
- Amphiregulin, ST2,and REG3α Biomarker Risk Algorithms as Predictors of Non-Relapse Mortality in Patients with Acute GVHD
- Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment
- Assessment of Risk Factors for Acute Kidney Injury with Machine Learning Tools in Children Undergoing Hematopoietic Stem Cell Transplantation
- Autologous human preclinical modeling of melanoma interpatient clinical responses to immunotherapeutics
- Blood-Derived Eye Drops for the Treatment of Corneal Neuropathic Pain
- CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation
- CD8<sup>+</sup> T cell-mediated rejection of allogenic human induced pluripotent stem cell-derived cardiomyocyte sheets in human PBMC-transferred NOG MHC double knockout mice
- Central Venous Access Device-Associated Skin Complications in Adults with Cancer: A Prospective Observational Study
- Chronic cutaneous graft-versus-host disease occurring exclusively on striae distensae
- Clinical Study of Allogeneic Hematopoietic Stem Cell Transplantation Patients with Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus
- Clinical study of the efficacies of ruxolitinib plus low-dose PTCY for acute GVHD prevention after haploidentical transplantation in malignant hematological diseases
- Collection efficiency of double- versus single-needle extracorporeal photopheresis
- Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis
- Comparable outcomes of allogeneic peripheral blood versus bone marrow hematopoietic stem cell transplantation from a sibling donor for pediatric patients
- Concomitant use of interleukin-2 and tacrolimus suppresses follicular helper T cell proportion and exerts therapeutic effect against lupus nephritis in systemic lupus erythematosus-like chronic graft versus host disease
- Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatment
- Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8<sup>+</sup> T cells in murine models of inflammation
- Donor <em>KIR</em> genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight
- Donor matters: Donor selection impact on hematopoietic stem cell transplantation outcomes in Hispanic patients with B-cell acute lymphocytic leukemia: Insights from a myeloablative HSCT study
- Donor regulatory T cells rapidly adapt to recipient tissues to control murine acute graft-versus-host disease
- Donor whole blood DNA methylation is not a strong predictor of acute graft versus host disease in unrelated donor allogeneic haematopoietic cell transplantation
- Early recovery of natural killer cells post T-cell depleted allogeneic stem cell transplantation using alemtuzumab "in the bag"
- Early utilization of Ruxolitinib in acute graft-versus-Host Disease after liver transplant
- Editorial: Hematopoietic stem cell transplantation: back to the future
- Effects of CD34<sup>+</sup> cell dose on engraftment and long-term outcomes after allogeneic bone marrow transplantation
- Effects of female bone marrow transplantation on male reproductive organs
- Endoscopic manifestation of intestinal transplant-associated microangiopathy after stem cell transplantation
- Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy
- Epidemiology, Microbiology, and Risk Factors of Bacterial Bloodstream Infections in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
- Establishment and Evaluation Strategy of an in vitro Cell Model of Bone Marrow Microenvironment Injury in Mouse Acute Graft-Versus-Host Disease
- Fewer severe infections with tranexamic acid in patients with hematologic malignancies
- Glutamine supplementation improves the activity and immunosuppressive action of induced regulatory T cells in vitro and in vivo
- Glycoengineered recombinant alpha1-antitrypsin results in comparable <em>in vitro</em> and <em>in vivo</em> activities to human plasma-derived protein
- Graft-versus-host disease after autologous stem cell transplantation in a recipient who underwent allogeneic stem cell transplantation 20 years earlier
- Haploidentical donor peripheral blood stem cell transplantation using third-party cord blood compared with matched unrelated donor transplantation for patients with hematologic malignancies
- Haploidentical hematopoietic stem cell transplantation with busulfan, cyclophosphamide, and fludarabine conditioning for X-linked adrenal cerebral leukodystrophy
- High yield killing of lymphoma cells by anti-CD22 CAR-NK cell therapy
- High-dose Alemtuzumab-Cyclosporine vs Tacrolimus-Methotrexate-Sirolimus for Chronic Graft-versus-Host Disease Prevention
- HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation
- Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape
- Immediate pain alleviation in oral mucositis and other oral ulcerative diseases through photobiomodulation therapy: the preemptive treatment concept
- Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies
- Immunomodulation by juglone alleviates acute graft-versus-host disease without compromising the graft-versus-leukaemia activity in mice
- Impact of prophylactic echinocandin on the development of neurological complications in patients receiving busulfan-containing conditioning regimens for stem cell transplantation: A single-center retrospective study
- Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect
- Insulin eye drops for severe refractory chronic ocular graft-versus-host disease
- Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies
- Lymphocyte Crossmatch Testing or Donor HLA-DP and -DQ Allele Typing Effectiveness in Single Cord Blood Transplantation for Patients with Anti-HLA antibodies Other Than Against HLA-A, -B, -C, and -DRB1
- Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD: a multicentre, randomized trial
- Minnelide suppresses GVHD and enhances survival while maintaining GVT responses
- Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT
- NELL1 membranous nephropathy: clinical associations provide mechanistic clues
- Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse Model
- Ophthalmic Manifestations in Patients with Blood Malignancies
- Pathogenesis and Therapeutic Prospects of Chronic Graft-Versus-Host Disease --Review
- PET/CT in leukemia: utility and future directions
- Post-transplant cyclophosphamide at 80 mg/kg with low dose post-engraftment anti-thymocyte globulin in haploidentical transplantation with myeloablative conditioning
- Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
- Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience
- Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation
- Post-transplant-cyclophosphamide and short-term Everolimus as graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and myeloma-Final results of the phase II OCTET-EVER trial
- PRRX1 upregulates PD-L1 in human mesenchymal stem cells
- Recent advancements in hematopoietic stem cell transplantation in Taiwan
- Reduction of product composition variability using pooled microbiome ecosystem therapy and consequence in two infectious murine models
- Safety and efficacy of chimeric antigen receptor T-cell therapy for acute myeloid leukemia: A subgroup based meta-analysis
- Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
- Short-term substitution of calcineurin inhibitors (CNI) with recombinant humanized anti-CD25 monoclonal antibody (Basiliximab) as aGVHD prophylaxis in CNI intolerant patients after allogeneic hematopoietic stem cell transplantation
- ST2 and Reg3α: Can they predict aGvHD, steroid refractoriness and transplant-related mortality in pediatric patients after HSCT?
- Steroid tapering after GVHD Rx: not too fast, not too slow
- Successful bridging therapy with alectinib prior to allogeneic stem cell transplantation for refractory ALK-positive anaplastic large cell lymphoma
- Successful maintenance treatment of disseminated nocardiosis with cerebral abscess in a severely immunocompromised patient allergic to trimethoprim-sulfamethoxazole using moxifloxacin and high-dose minocycline: A case report
- TCRαβ-depleted hematopoietic stem cell transplant and third-party CD45RA<sup>+</sup> depleted adoptive cell therapy for treatment of post-transplant parvovirus B19 aplastic crisis
- The Adverse Event Landscape of Stem Cell Transplant: Evidence for aGVHD Driving Early Transplant Associated Toxicities
- The application of umbilical cord blood-derived platelet gel for skin ulcers associated with chronic graft-versus-host disease in pediatrics: A randomized trial
- The effect of glucose-6-phosphate dehydrogenase deficiency on allogeneic hematopoietic stem cell transplantation in patients with hematological disorders
- The immunosuppressive drug cyclosporin A has an immunostimulatory function in CD8<sup>+</sup> T cells
- The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
- The predictive value of T-cell chimerism for disease relapse after allogeneic hematopoietic stem cell transplantation
- The role of immune reconstitution in relapse after allogeneic hematopoietic stem cell transplantation
- Transformation of Severe Aplastic Anemia into Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Rare Case Report
- Treosulfan- versus busulfan-based conditioning in allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: a single-center retrospective propensity score-matched cohort study
- Triazole antifungal drug interactions-practical considerations for excellent prescribing
- Type 2 cannabinoid receptor expression on microglial cells regulates neuroinflammation during graft versus host disease
- Unrelated umbilical cord blood transplantation with low-dose anti-thymocyte globulin for children with severe aplastic anemia: A case series
- Upfront allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia/lymphoma in first complete remission: a single-center study
- Use of machine learning models for the prognostication of liver transplantation: A systematic review
- Using Targeted Transcriptome and Machine Learning of Pre- and Post-Transplant Bone Marrow Samples to Predict Acute Graft-versus-Host Disease and Overall Survival after Allogeneic Stem Cell Transplantation
- γδ T cells in oral diseases